Ananth Ravi

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy

Gerard Morton, Merrylee McGuffin, Hans T. Chung et al. · Radiotherapy and Oncology · 2020 · 127 citations

Urology, Radiation Therapy, Medicine +5

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy

Gerard Morton, Hans T. Chung, Merrylee McGuffin et al. · Radiotherapy and Oncology · 2016 · 87 citations

Radiation Therapy, Medicine, Brachytherapy +5

Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial

Harvey Quon, Aldrich Ong, Patrick Cheung et al. · Radiotherapy and Oncology · 2018 · 69 citations

Adaptive Radiotherapy, Radiation Medicine, Radiation Therapy +7

Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial

Jure Murgić, Gerard Morton, Andrew Loblaw et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 68 citations

Urology, Surgical Oncology, Radiation Medicine +6

Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate

Shyam Bharat, Cynthia Kung, Ehsan Dehghan et al. · Brachytherapy · 2014 · 67 citations

Medical Ultrasound, Urology, Engineering +12